THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Start-up’s innovative cancer test gets boost

By Karen Weintraub
Globe Correspondent / April 24, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

A Cambridge start-up hopes to take some of the chance out of cancer care. Foundation Medicine Inc. this week secured a $25 million cash infusion from Third Rock Ventures to develop a comprehensive genetic test for cancerous tumors. (Full article: 812 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly